Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Original Article

Comparison of surgical resection versus transarterial chemoembolization with additional radiation therapy in patients with hepatocellular carcinoma with portal vein invasion

Danbi Lee, Han Chu Lee, Jihyun An, Ju Hyun Shim, Kang Mo Kim, Young-Suk Lim, Young-Hwa Chung, Yung Sang Lee

Clin Mol Hepatol. 2018;24(2):144-150. Published online January 16, 2018

DOI: https://doi.org/10.3350/cmh.2017.0041

View: 8326 Download: 170 Citations: 11

Review

Strategic application of radiotherapy for hepatocellular carcinoma

Seo Hee Choi, Jinsil Seong

Clin Mol Hepatol. 2018;24(2):114-134. Published online February 14, 2018

DOI: https://doi.org/10.3350/cmh.2017.0073

View: 13046 Download: 376 Citations: 37

Recent advances in transarterial embolotherapies in the treatment of hepatocellular carcinoma

Edward Wolfgang Lee, Sarah Khan

Clin Mol Hepatol. 2017;23(4):265-272. Published online November 8, 2017

DOI: https://doi.org/10.3350/cmh.2017.0111

View: 10318 Download: 349 Citations: 31

3

Concurrent Chemo - Radiation Therapy for Advanced Hepatocellular Carcinoma with Portal Vein Thrombosis

Jin Suk Kim, M.D., Kwang-Hyub Han, M.D., Do Yun Lee, M.D.* , Jin-Sil Seong, M.D.† , Young Hoon Youn, M.D., Jae Youn Cheong, M.D., Sang Hoon Ahn, M.D., Chae Yoon Chon, M.D., and Young Myoung Moon, M.D.

Clin Mol Hepatol. 2002;8(1):71-79. Published online January 1, 1970

View: 2726 Download: 19

1 |

Viewed By 5004	A decade of liver organoids: Advances in disease modeling
Viewed By 4760	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 3919	Hepatitis B core-related antigen: A novel and promising surrogate biomarker to guide anti-hepatitis B virus therapy
Viewed By 3042	MAFLD: How is it different from NAFLD?
Viewed By 2477	Management of refractory ascites

Cited By 118	KASL clinical practice guidelines: Management of nonalcoholic fatty liver disease
Cited By 54	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 52	From nonalcoholic fatty liver disease to metabolic-associated fatty liver disease: Big wave or ripple?
Cited By 46	Obesity and the risk of primary liver cancer: A systematic review and meta-analysis
Cited By 46	Lactobacillus attenuates progression of nonalcoholic fatty liver disease by lowering cholesterol and steatosis

Search